Artemis Investment Management LLP decreased its position in shares of Cardinal Health, Inc. (NYSE:CAH) by 66.6% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 63,359 shares of the company’s stock after selling 126,380 shares during the period. Artemis Investment Management LLP’s holdings in Cardinal Health were worth $4,561,000 as of its most recent filing with the SEC.
Other hedge funds have also made changes to their positions in the company. Charlemagne Capital Ltd. boosted its stake in Cardinal Health by 0.4% in the second quarter. Charlemagne Capital Ltd. now owns 2,527 shares of the company’s stock valued at $196,000 after buying an additional 10 shares in the last quarter. Alpha Windward LLC boosted its stake in Cardinal Health by 0.8% in the third quarter. Alpha Windward LLC now owns 2,133 shares of the company’s stock valued at $166,000 after buying an additional 16 shares in the last quarter. KCM Investment Advisors LLC boosted its stake in Cardinal Health by 0.3% in the third quarter. KCM Investment Advisors LLC now owns 5,778 shares of the company’s stock valued at $449,000 after buying an additional 17 shares in the last quarter. Geneva Advisors LLC boosted its stake in Cardinal Health by 0.4% in the third quarter. Geneva Advisors LLC now owns 6,840 shares of the company’s stock valued at $531,000 after buying an additional 25 shares in the last quarter. Finally, Johnson Investment Counsel Inc. boosted its stake in Cardinal Health by 0.4% in the third quarter. Johnson Investment Counsel Inc. now owns 8,987 shares of the company’s stock valued at $698,000 after buying an additional 34 shares in the last quarter. Institutional investors own 85.84% of the company’s stock.
Shares of Cardinal Health, Inc. (NYSE:CAH) traded up 0.7234% during midday trading on Monday, reaching $77.9599. 622,795 shares of the company’s stock were exchanged. The stock’s 50 day moving average is $74.76 and its 200-day moving average is $75.73. The stock has a market cap of $24.59 billion, a PE ratio of 18.7719 and a beta of 0.71. Cardinal Health, Inc. has a 12-month low of $62.70 and a 12-month high of $87.85.
Cardinal Health (NYSE:CAH) last issued its quarterly earnings data on Tuesday, February 7th. The company reported $1.34 EPS for the quarter, topping analysts’ consensus estimates of $1.23 by $0.11. The business had revenue of $33.10 billion for the quarter, compared to analysts’ expectations of $33.63 billion. Cardinal Health had a net margin of 1.06% and a return on equity of 25.52%. The business’s revenue was up 5.4% on a year-over-year basis. During the same quarter last year, the company earned $1.30 EPS. On average, equities analysts expect that Cardinal Health, Inc. will post $5.42 EPS for the current year.
The company also recently disclosed a quarterly dividend, which will be paid on Saturday, April 15th. Stockholders of record on Monday, April 3rd will be paid a dividend of $0.4489 per share. The ex-dividend date of this dividend is Thursday, March 30th. This represents a $1.80 dividend on an annualized basis and a dividend yield of 2.32%. Cardinal Health’s payout ratio is 43.17%.
“Artemis Investment Management LLP Decreases Stake in Cardinal Health, Inc. (CAH)” was first posted by sleekmoney and is the property of of sleekmoney. If you are accessing this article on another domain, it was copied illegally and reposted in violation of U.S. & international copyright & trademark legislation. The correct version of this article can be accessed at http://sleekmoney.com/artemis-investment-management-llp-decreases-stake-in-cardinal-health-inc-cah/1658421.html.
Several analysts have issued reports on CAH shares. Barclays PLC set a $88.00 target price on shares of Cardinal Health and gave the stock a “buy” rating in a research note on Monday, November 14th. Zacks Investment Research upgraded shares of Cardinal Health from a “sell” rating to a “hold” rating in a research note on Monday, November 14th. Leerink Swann set a $81.00 target price on shares of Cardinal Health and gave the stock a “hold” rating in a research note on Wednesday, February 8th. Vetr cut shares of Cardinal Health from a “buy” rating to a “hold” rating and set a $76.99 target price on the stock. in a research note on Tuesday, January 3rd. Finally, Mizuho cut shares of Cardinal Health from a “buy” rating to a “neutral” rating and set a $79.00 target price on the stock. in a research note on Tuesday, January 3rd. One research analyst has rated the stock with a sell rating, twelve have assigned a hold rating and five have issued a buy rating to the company. Cardinal Health has a consensus rating of “Hold” and an average target price of $88.54.
Cardinal Health Company Profile
Cardinal Health, Inc is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies.
Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAH).
This story was originally published by sleekmoney (http://sleekmoney.com) and is the sole property of sleekmoney. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at http://sleekmoney.com/artemis-investment-management-llp-decreases-stake-in-cardinal-health-inc-cah/1658421.html
Receive News & Ratings for Cardinal Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health Inc. and related companies with MarketBeat.com's FREE daily email newsletter.